That means that a healthy twenty-year-old Asian football player or a 17-year-old African-American marathon runner from a wealthy family will be automatically deemed at heightened risk to develop serious COVID illness—making them instantly eligible for monoclonal treatments upon testing positive and showing symptoms—while a White person of exactly the same age and health condition from an impoverished background would not be automatically eligible.This policy was first flagged by New York journalist Karol Markowicz, whose Twitter summary described it as "white people need not apply." That summary is not accurate. White people who are sick from COVID can still be eligible for antibody treatment, but only if they first demonstrate that they have "a medical condition that increases their risk for severe illness." But non-white people have the significant advantage of being automatically eligible without having to demonstrate that, since their non-white race is deemed to inherently constitute an increased risk of severe illness or death from COVID-19. In other words, when determining eligibility for life-saving treatments, New York state is explicitly prioritizing some races over others.